You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

immune-related adverse events

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Immune-related Adverse Event Trial in Durham (Medical chart review)

Enrolling by invitation
  • Cancer
  • Immune-related Adverse Event
  • Medical chart review
  • Durham, North Carolina
    Duke University Medical Center
Oct 20, 2023

EXploring Immune-related Adverse Events of Immune checkpoinT

Active, not recruiting
  • Cancer
  • +2 more
  • Immune checkpoint inhibitor
  • Paris, France
  • +1 more
Jul 5, 2023

Immunotherapy, Immune Checkpoint Inhibitors, Immune-related Adverse Event Trial in Amiens (blood retriewal)

Recruiting
  • Immunotherapy
  • +5 more
  • blood retriewal
  • Amiens, Picardie, France
    CHU Amiens Picardie
Apr 3, 2023

Immune-related Adverse Events Refractory to Standard Therapy and

Recruiting
  • Immune-related Adverse Event
  • Extracorporeal photopheresis
  • Other immunosuppressive or immunomodulatory drugs
  • Munich, Germany
    LMU Klinikum Hauttumorzentrum
Jan 17, 2023

Immune Checkpoint Inhibitors(ICPis)-Induced Endocrine

Completed
  • Immune Checkpoint Inhibitor
  • Endocrine Toxicity
    • Nanjing, Jiangsu, China
      First Affiliated Hospital, Nanjing Medical University
    Jan 6, 2023

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Nashville (Itacitinib, Corticosteroid, Endoscopic

    Not yet recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • Malignant Solid Neoplasm
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Dec 20, 2022

    Immune Related Adverse Events, Colitis, Hepatitis Trial in Freiburg (ECP)

    Recruiting
    • Immune Related Adverse Events
    • +3 more
    • Freiburg, Baden-Württemberg, Germany
      Medical Center - University of Freiburg Albert-Ludwigs-Universit
    Jun 9, 2022

    Neurological Immune-related Adverse Events

    Recruiting
    • Neurological Disease
    • Analysis of biomarkers and their correlation with clinical characteristics and outcome
    • Bron, France
      Centre de référence des syndromes neurologiques paranéoplasiques
    Jul 28, 2023

    Adverse Events in Patients Treated With Immune Check Point

    Recruiting
    • Immune-related Adverse Event
    • Antiinflammatory/DMARDs
    • Kristiansand, Norway
    • +4 more
    Sep 15, 2022

    Cancer, Immune System Disorder, Inflammatory Reaction Trial in Montreal

    Recruiting
    • Cancer
    • +3 more
      • Montreal, Quebec, Canada
        Jewish General Hospital
      Nov 30, 2021

      Advanced Malignant Solid Tumor Trial in Sacramento (CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc,

      Terminated
      Has Results
      • Advanced Malignant Solid Neoplasm
      • CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc
      • Placebo Administration
      • Sacramento, California
        University of California Davis Comprehensive Cancer Center
      Mar 8, 2022

      irAE Prediction of Anti-PD-1/L1 in Lung Cancer

      Recruiting
      • Immune Checkpoint Inhibitors
      • Lung Cancer
        • Beijing, China
          Peking Union Medical College Hospital
        Mar 31, 2022

        Pathways to Mitigate Immune-Related Adverse Events With Cancer

        Recruiting
        • Cancer
        • systemic corticosteroid or biologic
        • Denver, Colorado
        • +1 more
        Sep 8, 2021

        Severe Checkpoint Inhibitor Pneumonitis Trial in Beijing (Corticosteroids, Corticosteroids and Ruxolitinib)

        Recruiting
        • Severe Checkpoint Inhibitor Pneumonitis
        • Beijing, Beijing, China
          Department of Respiratory Medicine, Peking Union Medical College
        Jun 12, 2023

        Adverse Events-related Healthcare Resource Utilization and Costs

        Completed
        • Melanoma
        • East Hanover, New Jersey
          Novartis Pharmaceuticals
        Jan 27, 2023

        Suspicion of Cardiovascular Events on Immunecheckpoint

        Recruiting
        • Cancer
        • +3 more
        • No intervention for research purposes only
        • Paris, France
          Intitut Mutualiste Montsouris
        Mar 23, 2023

        Healthcare Resource Utilization and Costs of Immune Checkpoint

        Completed
        • Melanoma
          • East Hanover, New Jersey
            Novartis
          May 12, 2023

          Axitinib Therapy Management Study

          Withdrawn
          • Renal Cell Carcinoma
          • New York, New York
            Pfizer Inc.
          Mar 25, 2022

          Renal Cell Carcinoma Trial in London (Fecal Microbiota Transplantation)

          Recruiting
          • Renal Cell Carcinoma
          • Fecal Microbiota Transplantation
          • London, Ontario, Canada
            London Regional Cancer Program of the Lawson Health Research Ins
          Apr 5, 2022

          A Clinical and Biological Prospective Database of Patients

          Recruiting
          • Cancer
          • Estimation of the incidence of the irAE
          • Bron, France
          • +4 more
          Jul 26, 2021

          Immune Checkpoint Inhibitors (AUTENTIC)

          Recruiting
          • Cancer
          • +2 more
          • Treatment with immune checkpoint inhibitors.
          • Blood tests.
          • Vitoria, Álava, Spain
            Hospital Universitario Araba
          Aug 27, 2021

          Vitiligo, Skin Melanoma Trial in Bordeaux (skin swabs at lesional and non-lesional sites, skin swabs on skin)

          Not yet recruiting
          • Vitiligo
          • Skin Melanoma
          • skin swabs at lesional and non-lesional sites
          • skin swabs on skin
          • Bordeaux, France
            Service de Dermatologie - Hôpital Saint-André
          Jan 27, 2021

          Multi-Centre, Prospective, Non-Interventional Study to

          Recruiting
          • Immune Related Adverse Events
          • PD-1
          • Sintilimab Injection
          • Beijing, Beijing, China
            Cancer Hospital Chinese Academy of Medical Sciences
          Apr 7, 2021

          Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint

          Recruiting
          • Pneumonitis, Interstitial
          • +2 more
          • Immune checkpoint blockade
          • +2 more
          • Leuven, Flemish Brabant, Belgium
            Universitaire Ziekenhuizen Leuven
          Mar 18, 2021

          PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse

          Unknown status
          • Carcinoma, Non-Small-Cell Lung
          • Immune-Related Adverse Events
          • PD-1 inhibitor
          • Chemotherapy Drugs, Cancer
          • (no location specified)
          May 27, 2020